Professor David Attwell, Jodrell Professor of Physiology at UCL, and the study's co-lead, added: "With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of 'no-reflow' in heart attack patients, offering a potentially life-saving solution." Dr
Responsible clinics focus on balanced, evidence-based care, not shortcuts
Table of Contents: What is semaglutide used for
Patients dial to the correct dose and click to inject, so it's harder to make mistakes
Every buy now, pay later option for tirzepatide compared Afterpay is not the only game in town
Stay hydrated : Drinking plenty of water helps promote regular bowel movements and supports overall gut health